# SCINAI IMMUNOTHERAPEUTICS LT SPONSORED ADR

SCINAI IMMUNOTHERAPEUTICS LT SPONSORED ADR is a security (CUSIP 09073Q303) tracked across SEC portfolio filings. 5 institutional managers reported $15K on Form 13F as of 2026-03-31.

## Summary

- Issuer: SCINAI IMMUNOTHERAPEUTICS LT
- Class: SPONSORED ADR
- CUSIP: 09073Q303
- 13F holders: 5
- 13F value: $15K
- 13F period: 2026-03-31
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| XTX Topco Ltd | LONDON, X0 | $13K | 24,041 |
| [RHUMBLINE ADVISERS](https://search.stillhousedata.com/firm/107151) | BOSTON, MA | $1K | 1,878 |
| UBS Group AG | Zurich, V8 | $524 | 919 |
| MORGAN STANLEY | NEW YORK, NY | $33 | 58 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/09073Q303.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.